Paradoxical effect of prostacyclin infusion in a patient with primary pulmonary hypertension: A case report

Angiology

Volumn 55, Issue 3, 2004, Pages 341-344

  Younger, Jared R ^a,b   Lui, Charles Y ^a,b  

^a University of Arizona ^*

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DILTIAZEM; DOBUTAMINE; FUROSEMIDE; NIFEDIPINE; PHENDIMETRAZINE TARTRATE; PROSTACYCLIN; SPIRONOLACTONE; WARFARIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG INFUSION; FEMALE; HUMAN; LUNG ARTERY; LUNG TRANSPLANTATION; PULMONARY HYPERTENSION; TREATMENT OUTCOME; VASODILATATION; WEIGHT REDUCTION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; EPOPROSTENOL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; PLATELET AGGREGATION INHIBITORS; PREGNANCY; PULMONARY ARTERY;

EID: 2442502371     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970405500315     Document Type: Article

References (9)

1. Rubin LJ: Primary pulmonary hypertension. N Engl J Med 336:111-117, 1997.
2. Palevsky HI, Fishman AP: Chronic cor pulmonale. Etiology and management. JAMA 263:2347-2353, 1990.
3. D'Alonzo GE, Barst RJ, Ayres SM, et al: Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115:343-349, 1991.
4. Barst RJ, Rubin LJ, Long WA, et al: Epoprostenol therapy for primary pulmonary hypertension: A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 334:296-302, 1996.
5. Abenhaim L, Moride Y, Brenot F, et al: Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group. N Engl J Med 335:609-616, 1996.
6. Nall KC, Rubin LJ, Lipskind S, et al: Reversible pulmonary hypertension associated with anorexigen use. Am J Med 91:97-99, 1991.
7. Rich S, Kaufmann E, Levy PS: The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 327:76-81, 1992.
8. Long W, Rubin L, Barst RJ, et al: Randomized trial of conventional therapy alone vs conventional therapy plus continuous infusion of prostacyclin in primary pulmonary hypertension. Am Rev Respir Dis 149:A538, 1993.
9. Higgenbottani TW, Spiegelhalter D, Scott JP, et al: The value of prostacyclin (epoprostenol) and heart-lung transplantation for severe pulmonary hypertension. Br Heart J 70:36640, 1993.